Skip to main content

and
  1. Article

    Open Access

    C-reactive protein as robust laboratory value associated with prognosis in patients with stage III non-small cell lung cancer (NSCLC) treated with definitive radiochemotherapy

    To evaluate the prognostic value of biomarkers from peripheral blood obtained as routine laboratory assessment for overall survival in a cohort of stage III non-small cell lung cancer (NSCLC) patients treated ...

    Cedric Richlitzki, Marcel Wiesweg, Martin Metzenmacher, Nika Guberina in Scientific Reports (2024)

  2. Article

    Open Access

    Neoadjuvant nivolumab with or without relatlimab in resectable non-small-cell lung cancer: a randomized phase 2 trial

    Antibodies targeting the immune checkpoint molecules PD-1, PD-L1 and CTLA-4, administered alone or in combination with chemotherapy, are the standard of care in most patients with metastatic non-small-cell lun...

    Martin Schuler, Kristof Cuppens, Till Plönes, Marcel Wiesweg in Nature Medicine (2024)

  3. Article

    Open Access

    Body composition impacts outcome of bronchoscopic lung volume reduction in patients with severe emphysema: a fully automated CT-based analysis

    Chronic Obstructive Pulmonary Disease (COPD) is characterized by progressive and irreversible airflow limitation, with individual body composition influencing disease severity. Severe emphysema worsens symptom...

    Johannes Wienker, Kaid Darwiche, Nele Rüsche, Erik Büscher in Scientific Reports (2024)

  4. Article

    Open Access

    Favorable survival outcomes in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer sequentially treated with a tyrosine kinase inhibitor and osimertinib in a real-world setting

    EGFR tyrosine kinase inhibitor (TKI) therapy in EGFR-mutated lung cancer is limited by acquired resistance. In half of the patients treated with first/second-generation (1st/2nd gen) TKI, resistance is associa...

    Oliver Kraskowski, Jan A. Stratmann in Journal of Cancer Research and Clinical On… (2023)

  5. Article

    Open Access

    Rabbit fever: granulomatous inflammation by Francisella tularensis mimics lung cancer in dual tracer 18FDG and 68Ga-FAPI PET/CT

    Mathias Meetschen, Patrick Sandach in European Journal of Nuclear Medicine and M… (2023)

  6. Article

    Open Access

    Prediction of malignant lymph nodes in NSCLC by machine-learning classifiers using EBUS-TBNA and PET/CT

    Accurate determination of lymph-node (LN) metastases is a prerequisite for high precision radiotherapy. The primary aim is to characterise the performance of PET/CT-based machine-learning classifiers to predic...

    Maja Guberina, Ken Herrmann, Christoph Pöttgen, Nika Guberina in Scientific Reports (2022)

  7. Article

    Open Access

    Long-term survival of patients with central or > 7 cm T4 N0/1 M0 non-small-cell lung cancer treated with definitive concurrent radiochemotherapy in comparison to trimodality treatment

    To examine long-term-survival of cT4 cN0/1 cM0 non-small-cell lung carcinoma (NSCLC) patients undergoing definitive radiochemotherapy (ccRTx/CTx) in comparison to the trimodality treatment, neoadjuvant radiochemo...

    Nika Guberina, Christoph Pöttgen, Martin Schuler, Maja Guberina in Radiation Oncology (2022)

  8. Article

    Open Access

    Patterns of nodal spread in stage III NSCLC: importance of EBUS-TBNA and 18F-FDG PET/CT for radiotherapy target volume definition

    The aim of this study was to compare the pattern of intra-patient spread of lymph-node (LN)-metastases within the mediastinum as assessed by 18F-FDG PET/CT and systematic endobronchial ultrasound-guided transbron...

    Maja Guberina, Kaid Darwiche, Hubertus Hautzel, Christoph Pöttgen in Radiation Oncology (2021)

  9. Article

    Open Access

    Impact of EBUS-TBNA in addition to [18F]FDG-PET/CT imaging on target volume definition for radiochemotherapy in stage III NSCLC

    [18F]FDG-PET/CT is the standard imaging-technique for radiation treatment (RT) planning in locally advanced non-small cell lung cancer (NSCLC). The purpose of this study was to examine the additional value of end...

    Maja Guberina, Kaid Darwiche in European Journal of Nuclear Medicine and M… (2021)

  10. Article

    Open Access

    N-staging in large cell neuroendocrine carcinoma of the lung: diagnostic value of [18F]FDG PET/CT compared to the histopathology reference standard

    Large cell neuroendocrine carcinoma of the lung (LCNEC) is a rare entity occurring in less than 4% of all lung cancers. Due to its low differentiation and high glucose transporter 1 (GLUT1) expression, LCNEC d...

    Hubertus Hautzel, Yazan Alnajdawi, Wolfgang P. Fendler in EJNMMI Research (2021)

  11. No Access

    Article

    Bronchial Thermoplasty Including the Middle Lobe Bronchus Significantly Improves Lung Function and Quality of Life in Patients Suffering from Severe Asthma

    Bronchial Thermoplasty (BT) is indicated in patients suffering from severe and symptomatic bronchial asthma despite maximal medical therapy. However, treatment of the right middle lobe (RML) bronchus is curren...

    Stephan Eisenmann, Wolfgang Schütte, Faustina Funke, Filiz Oezkan, Shaheen Islam in Lung (2019)

  12. Article

    Open Access

    Bleeding risk of transbronchial cryobiopsy compared to transbronchial forceps biopsy in interstitial lung disease – a prospective, randomized, multicentre cross-over trial

    Bronchoscopic cryobiopsy is a new method of bronchoscopic tissue sampling in interstitial lung disease. In case of transbronchial biopsies, the resultant tissue samples are of high quality, and the lung parenc...

    Juergen Hetzel, Ralf Eberhardt, Christoph Petermann in Respiratory Research (2019)

  13. No Access

    Article

    Impact of RAS mutation subtype on clinical outcome—a cross-entity comparison of patients with advanced non-small cell lung cancer and colorectal cancer

    Mutated RAS onco-proteins are key drivers across many cancers. The distribution of somatic RAS mutations varies between cancer entities. Retrospective analyses have associated some RAS mutations with distinct cli...

    Marcel Wiesweg, Stefan Kasper, Karl Worm, Thomas Herold, Henning Reis in Oncogene (2019)

  14. Article

    Open Access

    Prognostic value of MIB-1 proliferation index in solitary fibrous tumors of the pleura implemented in a new score – a multicenter study

    Although the majority of solitary fibrous tumors of the pleura (SFTP) follow a benign course, 10–25% of patients suffer from recurrence or metastatic disease. Several scoring models have been proposed to predi...

    Matthias Diebold, Alex Soltermann, Selma Hottinger, Sarah R. Haile in Respiratory Research (2017)

  15. Article

    Open Access

    Tissue is the issue and tissue competition. Re-biopsy for mutation T790: where and why?

    Lung cancer is still the leading cause of death among all cancers. During the last 15 years, pharmacogenomics of lung cancer have established targeted therapy with tyrosine kinase inhibitors (TKIs) for epiderm...

    Paul Zarogoulidis, Mina Gaga, Haidong Huang in Clinical and Translational Medicine (2017)

  16. No Access

    Article

    Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patients

    Lung cancer accounts for one in five cancer deaths. Broad screening strategies for high-risk populations are unavailable, and the validation of biomarkers for early cancer detection remains a prime interest. T...

    Jens Köhler, Martin Schuler in Journal of Cancer Research and Clinical On… (2016)

  17. Article

    Open Access

    Endometriosis of the lung: report of a case and literature review

    This paper reports a case of endometriosis of the lung in a 29-year-old woman with long-term periodic catamenial hemoptysis. A chest computed tomography image obtained during menstruation revealed a radiograph...

    Haidong Huang, Chen Li, Paul Zarogoulidis in European Journal of Medical Research (2013)

  18. No Access

    Article

    Correlation analysis on data sets to detect infectious agents in the airways by ion mobility spectrometry of exhaled breath

    A correlation analysis of peaks found in IMS-Chromatograms was carried out to show the potential of the method in clinical applications. As an example, the data of exhaled breath of patients suffering infectio...

    Sasidhar Maddula, Thomas Rabis in International Journal for Ion Mobility Spe… (2011)

  19. No Access

    Article

    Bronchoscopically Obtained Volatile Biomarkers in Lung Cancer

    The exhaled breath of lung cancer patients contains volatile organic compounds (VOCs) that differ from those in healthy individuals. These VOCs can be detected with methods such as ion mobility spectrometry (I...

    Kaid Darwiche, Joerg Ingo Baumbach, Urte Sommerwerck, Helmut Teschler, Lutz Freitag in Lung (2011)

  20. No Access

    Article

    Detection of volatile organic compounds (VOCs) in exhaled breath of patients with chronic obstructive pulmonary disease (COPD) by ion mobility spectrometry

    COPD is a disease characterised by a chronic inflammation of the airways and a not fully reversible airway obstruction. The spirometry is considered as gold-standard to diagnose the disease and to grade its se...

    Vasiliki Bessa, Kaid Darwiche in International Journal for Ion Mobility Spe… (2011)